OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Alkermes PLC/  IE00B56GVS15  /

NASDAQ
9/26/2024  10:00:00 PM Chg. +0.7400 Volume Bid12:56:13 AM Ask12:56:13 AM Market Capitalization Dividend Y. P/E Ratio
27.1700USD +2.80% 2.14 mill.
Turnover: 44.7 mill.		 25.2000Bid Size: 300 27.3500Ask Size: 200 4.47 bill.USD - 12.70
GlobeNewswire 8/19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 8/13 Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progr...
GlobeNewswire 7/30 ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
GlobeNewswire 7/4 Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns
GlobeNewswire 3/26 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Up...
GlobeNewswire 3/6 Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GlobeNewswire 1/18 SediVision Wastewater Technology Announces New Company Vice President
GlobeNewswire 1/8 Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
GlobeNewswire 12/4/2023 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
GlobeNewswire 11/15/2023 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 9/26/2023 OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
GlobeNewswire 9/11/2023 Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire 8/29/2023 Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
GlobeNewswire 3/28/2022 Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business...
GlobeNewswire 3/16/2022 Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Newsfile Corp 3/15/2022 Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development
GlobeNewswire 3/15/2022 Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 3/8/2022 Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surg...
GlobeNewswire 3/2/2022 Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®
GlobeNewswire 2/10/2022 Finch Therapeutics Announces Additions to Senior Leadership Team
GlobeNewswire 1/24/2022 Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
GlobeNewswire 12/6/2021 AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire 11/22/2021 Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
GlobeNewswire 11/4/2021 Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 9/8/2021 Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer